|View printer-friendly version|
|Avanir Pharmaceuticals Announces Date of Fiscal 2011 Second Quarter Financial Results and Conference Call|
ALISO VIEJO, Calif., May 2, 2011/PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended March 31, 2011 after market close on Monday, May 9, 2011. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.
Webcast information: Visit http://www.avanir.com.
A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-800-642-1687 for domestic callers, or +1-706-645-9291 for international callers, and entering reservation code 62329359.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR™ and NUEDEXTA® are trademarks owned by Avanir Pharmaceuticals, Inc.
©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.
SOURCE Avanir Pharmaceuticals, Inc.
May 02, 2011